Ashwagandha Extract Capsules
Withania somnifera root extract
- Dosage Form
- Capsule
- Strength
- 300 mg / 500 mg extract (standardised withanolides)
- HS Code
- 1302.19
- MOQ
- MOQ on request
Target markets: US, EU/UK, Middle East, SE Asia
Try: Paracetamol, Amoxicillin, Dolutegravir, HS code, Africa, RCMC
A semi-regulated, higher-margin corridor for generics, nutraceuticals and devices. Regulatory bodies such as SFDA (Saudi Arabia) and MoHAP (UAE) generally accept a WHO-GMP + COPP dossier, though several conduct their own plant inspection, and halal certification is a common buyer requirement.
Countries: United Arab Emirates, Saudi Arabia
Pathway
SFDA (Saudi Arabia), MoHAP (UAE) and equivalent Gulf regulators.
Plant Requirement
WHO-GMP + COPP is generally accepted; some Gulf regulators conduct their own plant inspection for higher-risk categories.
Timeline
12–36 months per product
Barrier to Entry
Medium
Good margins for generics, nutraceuticals and devices, best approached in year two or three once documentation processes are established, per the region's semi-regulated status.
It's typically a year-two or year-three market rather than a starting corridor — the semi-regulated registration process and local-agent requirement take longer to establish than the emerging-market route.
Withania somnifera root extract
Target markets: US, EU/UK, Middle East, SE Asia
Cetirizine Dihydrochloride
Target markets: Africa, SE Asia, LatAm, Middle East
Single-use disposable syringe with needle
Target markets: Africa, SE Asia, Middle East, LatAm
Multivitamin & Multimineral Formula
Target markets: US, EU/UK, Middle East, SE Asia
Omega-3 fatty acids (EPA/DHA)
Target markets: US, EU/UK, Middle East
Omeprazole
Target markets: Africa, SE Asia, LatAm, Middle East